| Universal influenza vaccines: Shifting to better vaccines FB Scorza, V Tsvetnitsky, JJ Donnelly Vaccine 34 (26), 2926-2933, 2016 | 179 | 2016 |
| H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge F Krammer, I Margine, R Hai, A Flood, A Hirsh, V Tsvetnitsky, D Chen, ... Journal of virology 88 (4), 2340-2343, 2014 | 125 | 2014 |
| Fatty acyl-CoA binding domain of the transcription factor FadR: characterization by deletion, affinity labeling, and isothermal titration calorimetry CC DiRusso, V Tsvetnitsky, P Højrup, J Knudsen Journal of Biological Chemistry 273 (50), 33652-33659, 1998 | 69 | 1998 |
| Evaluating Burkholderia pseudomallei Bip proteins as vaccines and Bip antibodies as detection agents C Druar, F Yu, JL Barnes, RT Okinaka, N Chantratita, S Beg, CW Stratilo, ... FEMS Immunology & Medical Microbiology 52 (1), 78-87, 2008 | 68 | 2008 |
| Assessment of human immune responses to H7 avian influenza virus of pandemic potential: Results from a placebo–controlled, randomized double–blind phase I study of live … L Rudenko, I Kiseleva, AN Naykhin, M Erofeeva, M Stukova, S Donina, ... PloS one 9 (2), e87962, 2014 | 64 | 2014 |
| Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: results from a placebo-controlled, randomized double-blind phase I study L Rudenko, I Kiseleva, M Stukova, M Erofeeva, A Naykhin, S Donina, ... Vaccine 33 (39), 5110-5117, 2015 | 33 | 2015 |
| Preparation and characterization of monopegylated human granulocyte-macrophage colony-stimulating factor DL Lee, I Sharif, S Kodihalli, DIH Stewart, V Tsvetnitsky Journal of Interferon & Cytokine Research 28 (2), 101-112, 2008 | 31 | 2008 |
| Development and pre-clinical evaluation of two LAIV strains against potentially pandemic H2N2 influenza virus I Isakova-Sivak, J de Jonge, T Smolonogina, A Rekstin, G van Amerongen, ... PloS one 9 (7), e102339, 2014 | 30 | 2014 |
| Live attenuated influenza vaccines against highly pathogenic H5N1 avian influenza: Development and preclinical characterization N Larionova, I Kiseleva, I Isakova-Sivak, A Rekstin, I Dubrovina, ... Vaccines Vaccination 4 (8), 208, 2013 | 24 | 2013 |
| Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine DM Carter, CE Bloom, GA Kirchenbaum, V Tsvetnitsky, I Isakova-Sivak, ... Vaccine 33 (1), 108-116, 2015 | 21 | 2015 |
| Purification and characterization of recombinant Streptomyces griseus aminopeptidase SX Ni, D Cossar, A Man, K Norek, D Miller, C Kearse, V Tsvetnitsky Protein expression and purification 30 (1), 62-68, 2003 | 15 | 2003 |
| Characterization of phospholipid methylation in rat brain myelin V Tsvetnitsky, L Auchi, A Nicolaou, WA Gibbons Biochemical Journal 307 (1), 239-244, 1995 | 14 | 1995 |
| S-adenosyl-l-homocysteine and 5′-methylthioadenosine inhibit binding of [3H] flunitrazepam to rat brain membranes V Tsvetnitsky, IC Campbell, WA Gibbons European journal of pharmacology 282 (1-3), 255-258, 1995 | 10 | 1995 |
| PATH Influenza Vaccine Project: accelerating the development of new influenza vaccines for low-resource countries KM Neuzil, V Tsvetnitsky, LJ Nyari, RA Bright, JW Boslego, ... Expert review of vaccines 11 (8), 939-947, 2012 | 6 | 2012 |
| Use of transient transfection for cGMP manufacturing of eOD-GT8 60mer, a self-assembling nanoparticle germline-targeting HIV-1 vaccine candidate VK Sharma, V Tsvetnitsky, S Menis, ET Brower, E Sayeed, J Ackland, ... bioRxiv, 2022.09. 30.510310, 2022 | 2 | 2022 |
| Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam HV Thang, VM Huong, JC Victor, CB Van, NT Nga, NP Cuong, ... Vaccine 36 (46), 6918-6925, 2018 | 2 | 2018 |
| The purification and molecular weight determination of rat liver microsomal phospholipid N-methyltransferase WA Gibbons, L Auchi, K McBride, AN Fonteh, B Larijani, V Tsvetnitsky, ... Biochemical Society Transactions 21 (4), 449S-449S, 1993 | 2 | 1993 |
| Isozymes of rat brain myelin phospholipid-N-methyltransferase V TSVETNITSKY, L AUCHI, FA YEBOAH, WA GIBBONS Biochemical Society Transactions 21 (4), 489S-489S, 1993 | 1 | 1993 |
| Use of Transient Transfection for cGMP Manufacturing of eOD-GT8 60mer, a Self-Assembling Nanoparticle Germline-Targeting HIV-1 Vaccine Candidate VK Sharma, S Menis, ET Brower, E Sayeed, J Ackland, A Lombardo, ... Pharmaceutics 16 (6), 742, 2024 | | 2024 |
| Safety and immunogenicity of inactivated monovalent influenza A/H1N1 vaccine candidate manufactured in Vietnam. HVT Ho Vinh Thang, VMH Vu Minh Huong, JC Victor, CBV Cao Bao Van, ... | | 2018 |
